Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
106<br />
<strong>Solvay</strong> Global Annual Report 2005<br />
Information<br />
for shareholders<br />
SOLVAY SHARE PERFORMANCE<br />
The <strong>Solvay</strong> share in 2005: average price and trading volumes up sharply<br />
EUR<br />
110<br />
105<br />
100<br />
95<br />
90<br />
85<br />
80<br />
75<br />
70<br />
share price Volume<br />
J F M A M J J A S O N D<br />
After rising strongly by 19% in 2004, the <strong>Solvay</strong> share<br />
price rose by another 16% in 2005. This positive<br />
evolution demonstrates strong investor interest in the<br />
Group’s activities and the successful implementation<br />
of its strategy. It also refl ects the Group’s strongly<br />
improved results in a more favorable economic<br />
environment than in 2004.<br />
The highest price was EUR 104.1 (November 11,<br />
2005), compared to EUR 83.9 in 2004, and represents<br />
a new record for the <strong>Solvay</strong> share. The average price<br />
1 500 000<br />
1 200 000<br />
900 000<br />
600 000<br />
300 000<br />
during 2005 (EUR 90.3) was higher than the highest<br />
price in 2004. The lowest price during the year was<br />
EUR 79.95 (January 14, 2005), compared with EUR<br />
64.1 in 2004.<br />
Average daily trading volumes increased signifi cantly in<br />
2005 (+ 62%) to above 170 000 shares, compared to<br />
105 000 shares in 2004. We note in particular record<br />
daily trading volumes of the order of 265 000 shares in<br />
November 2005.<br />
0